Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage
- PMID: 35501854
- PMCID: PMC9063270
- DOI: 10.1186/s12954-022-00624-6
Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage
Abstract
Background: In the context of the current U.S. injection drug use epidemic, targeted public health harm reduction strategies have traditionally focused on overdose prevention and reducing transmission of blood-borne viral infections. Severe bacterial infections (SBI) associated with intravenous drug use have been increasing in frequency in the U.S. over the last decade. This qualitative study aims to identify the risk factors associated with SBI in hospitalized individuals with recent injection drug use.
Methods: Qualitative analysis (n = 15) was performed using an in-depth, semi-structured interview of participants admitted to Bellevue Hospital, NYC, with SBI and recent history of injection drug use. Participants were identified through a referral from either the Infectious Diseases or Addition Medicine consultative services. Interviews were transcribed, descriptively coded, and analyzed for key themes.
Results: Participants reported a basic understanding of prevention of blood-borne viral transmission but limited understanding of SBI risk. Participants described engagement in high risk injection behaviors prior to hospitalization with SBI. These practices included polysubstance use, repetitive tissue damage, nonsterile drug diluting water and multipurpose use of water container, lack of hand and skin hygiene, re-use of injection equipment, network sharing, and structural factors leading to an unstable drug injection environment. Qualitative analysis led to the proposal of an Ecosocial understanding of SBI risk, detailing the multi-level interplay between individuals and their social and physical environments in producing risk for negative health outcomes.
Conclusions: Structural factors and injection drug use networks directly impact drug use, injection drug use practices, and harm reduction knowledge, ultimately resulting in tissue damage and inoculation of bacteria into the host and subsequent development of SBI. Effective healthcare and community prevention efforts targeted toward reducing risk of bacterial infections could prevent long-term hospitalizations, decrease health care expenditures, and reduce morbidity and mortality.
Keywords: Injection drug use; Risk factors; Severe bacterial infection; Tissue damage.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study.J Addict Med. 2023 May-Jun 01;17(3):e202-e205. doi: 10.1097/ADM.0000000000001099. Epub 2022 Oct 16. J Addict Med. 2023. PMID: 37267185
-
Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management.Adv Wound Care (New Rochelle). 2021 Oct;10(10):571-582. doi: 10.1089/wound.2020.1243. Epub 2021 Jun 14. Adv Wound Care (New Rochelle). 2021. PMID: 33913781 Free PMC article.
-
Injection risk norms and practices among migrant Puerto Rican people who inject drugs in New York City: The limits of acculturation theory.Int J Drug Policy. 2019 Jul;69:60-69. doi: 10.1016/j.drugpo.2019.03.016. Epub 2019 Jun 10. Int J Drug Policy. 2019. PMID: 31196730 Free PMC article.
-
Infectious Complications of Injection Drug Use.Med Clin North Am. 2022 Jan;106(1):187-200. doi: 10.1016/j.mcna.2021.08.006. Med Clin North Am. 2022. PMID: 34823730 Review.
-
How I manage severe bacterial infections in people who inject drugs.Clin Microbiol Infect. 2024 Jul;30(7):877-882. doi: 10.1016/j.cmi.2024.01.022. Epub 2024 Feb 3. Clin Microbiol Infect. 2024. PMID: 38316359 Review.
Cited by
-
Assessment of Bacterial Infections and Antibiotic Regimens in Intravenous Drug Users.Cureus. 2023 Sep 21;15(9):e45716. doi: 10.7759/cureus.45716. eCollection 2023 Sep. Cureus. 2023. PMID: 37868523 Free PMC article. Review.
-
Opportunistic pathogens and polycocktail drugs fuel dynamic public health threats during the opioid crisis.PLoS One. 2025 Aug 12;20(8):e0326200. doi: 10.1371/journal.pone.0326200. eCollection 2025. PLoS One. 2025. PMID: 40794717 Free PMC article.
-
U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations.Harm Reduct J. 2025 Jun 8;22(1):101. doi: 10.1186/s12954-025-01238-4. Harm Reduct J. 2025. PMID: 40484964 Free PMC article. Review.
-
Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances.Subst Use. 2024 Aug 21;18:29768357241272374. doi: 10.1177/29768357241272374. eCollection 2024 Jan-Dec. Subst Use. 2024. PMID: 39175912 Free PMC article.
-
The application prospect of microneedles for sports injuries: a narrative review.Ann Med. 2025 Dec;57(1):2541092. doi: 10.1080/07853890.2025.2541092. Epub 2025 Aug 7. Ann Med. 2025. PMID: 40771103 Free PMC article. Review.
References
-
- Hope V. Neglected infections, real harms: a global scoping of injection-related bacterial infections and responses. In: Harm Reduction International. 2010; p. 89–95.
-
- Gray ME, Rogawski McQuade ET, Scheld WM, Dillingham RA. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018;18(1):1–9. doi: 10.1186/s12879-017-2892-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical